These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 18313248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G, Laganà D, Ianniello A, Mangini M, Fontana F, Cotta E, Concollato L, Marconi A, Recaldini C, Dionigi G, Rovera F, Boni L, Cuffari S, Fugazzola C.
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD, Thomas J, Lucas SM, Bensalah K, Lotan Y, Trimmer C, Cadeddu JA.
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MRI-guided percutaneous laser ablation of small renal cell carcinoma: Initial clinical experience.
    Kariniemi J, Ojala R, Hellström P, Sequeiros RB.
    Acta Radiol; 2010 May; 51(4):467-72. PubMed ID: 20380606
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA.
    Cancer; 2010 Jul 01; 116(13):3135-42. PubMed ID: 20564644
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y, Kawanaka K, Ikeda O, Tamura Y, Yamashita Y.
    Acta Radiol; 2012 May 01; 53(4):410-4. PubMed ID: 22393159
    [Abstract] [Full Text] [Related]

  • 12. Percutaneous radiofrequency ablation of renal tumours: case series of 11 tumours and review of published work.
    Watkins TW, Parkinson R.
    Australas Radiol; 2007 Oct 01; 51(5):412-9. PubMed ID: 17803791
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K, Yamakado K, Kinbara H, Nakatsuka A, Takeda K, Sugimura Y.
    Int J Urol; 2007 Jul 01; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intermediate oncological outcomes of percutaneous radiofrequency ablation for small renal tumors: initial experience.
    Nitta Y, Tanaka T, Morimoto K, Makino T, Nishikawa N, Tashiro K, Naganuma T, Iguchi T, Matsuoka T, Nakatani T.
    Anticancer Res; 2012 Feb 01; 32(2):615-8. PubMed ID: 22287753
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.